We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Protection of Pharmaceutical IP in China

01 March 2009

CPB Monthly
The center of the global pharmaceutical industry is shifting eastward. Lured by China's inexpensive, highly-skilled workforce and booming consumer market, multinational pharmaceutical companies are increasingly exporting their research and development activities to China. Despite burgeoning foreign investment in China's pharmaceutical sector, however, foreign invested companies account for less than thirty percent of sales. In this highly fragmented market, domestic companies dominate. And the Chinese pharmaceutical sector grows at double digit rates, many of these domestic companies are poised to become future leaders in the global industry.
Loading data